Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Identification of LAG3+ T Cell Populations in the Tumor Microenvironment of Classical Hodgkin Lymphoma and B-Cell Non-Hodgkin Lymphoma

Katsuyoshi Takata, MD PhD, Tomohiro Aoki, MD PhD, Lauren C. Chong, MSc, Katy Milne, Tomoko Miyata-Takata, MD PhD, Karanvir Singh, Talia Goodyear, Pedro Farinha, MD PhD, Graham W. Slack, MD, Laurie H. Sehn, MDMPH, Kerry J. Savage, MDMSc, Brad H Nelson, David W. Scott, MBChB, PhD, Christian Steidl, MD

Blood (2020) 136 (Supplement 1): 19.

https://doi.org/10.1182/blood-2020-141462

Published: 2020

Journal Articles

Rituximab Monotherapy Compared to Observation in Patients with Newly Diagnosed Asymptomatic Advanced Stage Follicular Lymphoma: A Retrospective Population-Based Analysis

Sarah E. Perry, MD MSc, Derrick G. Lee, PhD, Ciara L. Freeman, MSc, MBBChir, Diego Villa, MDMPH, Alina S. Gerrie, MD MPH, Pedro Farinha, MD PhD, Jeffrey W. Craig, MD PhD, Graham W. Slack, MD, Joseph M. Connors, MD, David W. Scott, MBChB, PhD, Kerry J. Savage, BSc, MD MSc, Laurie H. Sehn, MDMPH

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-136457

Published: 2020

Journal Articles

Single Cell Profiling Reveals Unique CXCL13 Positive T Cell Subsets in the Tumor Microenvironment of Lymphocyte Rich Classic Hodgkin Lymphoma

Tomohiro Aoki, MD PhD, Lauren C. Chong, MSc, Katsuyoshi Takata, MD PhD, Katy Milne, Elizabeth Chavez, BSc, Cg RT, Tomoko Miyata-Takata, MD PhD, Susana Ben-Neriah, BSc, Doria Unrau, Adele Telenius, Merrill Boyle, BSc, Pedro Farinha, MD PhD, Andrew P. Weng, MD, Kerry J. Savage, MDMSc, David W. Scott, MBChB, PhD, Sohrab P Shah, Brad H. Nelson, Christian Steidl, MD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-134929

Published: 2020

Journal Articles

Long-Term Follow-up of a PET-Guided Approach to Treatment of Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)

Laurie H Sehn, MD, David W. Scott, MBChB, PhD, Diego Villa, MD FRCPC, Alina S Gerrie, MD MPH, Ciara L Freeman, MSc, MBBChir, Christina Aquino Parsons, MD, Tom Pickles, MD, Andrea Lo, MD, Pedro Farinha, MD PhD, Graham W Slack, MD PhD, Don Wilson, MD, R. Petter Tonseth, MD, Joseph M. Connors, MD, Kerry J Savage, BSc, MD MSc

Blood (2019) 134 (Supplement_1): 401.

https://doi.org/10.1182/blood-2019-128722

Published: 2019

Journal Articles

Single Cell Transcriptome Analysis Reveals Disease-Defining T Cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma

Blood (2019) 134 (Supplement_1): 547.

https://doi.org/10.1182/blood-2019-121584

Published: 2019

Journal Articles

TP53 Expression Correlates with TP53 Mutations and Is an Independent Predictor of Clinical Outcome in Patients with DLBCL Treated with R-CHOP

Pedro Farinha, MD PhD, Daisuke Ennishi, MD PhD, Anja Mottok, MD PhD, Susana Ben-Neriah, BSc, Barbara Meissner, PhD, Merrill Boyle, BSc, Jeffrey W. Craig, MD PhD, Graham W Slack, MD, Diego Villa, MD MPH, Kerry J Savage, BSc, MD MSc, Laurie H Sehn, MD, Ryan D. Morin, PhD, Marco A. Marra, PhD, Joseph M. Connors, MD, Randy D. Gascoyne, MD, Christian Steidl, MD, David W. Scott, MBChB, PhD

Blood (2019) 134 (Supplement_1): 3964.

https://doi.org/10.1182/blood-2019-121943

Published: 2019

Journal Articles

PRAME Expression Is Correlated with Treatment Outcome and Specific Features of the Tumor Microenvironment in Classical Hodgkin Lymphoma

Katsuyoshi Takata, MD PhD, Lauren C. Chong, MSc, Avinash Thakur, PhD, Tomohiro Aoki, MD PhD, Anja Mottok, MD PhD, Elizabeth Chavez, BSc, Cg RT, Pedro Farinha, MD PhD, Graham W Slack, MD, Pamela Hoodles, Sohrab P Shah, David W. Scott, MBChB, PhD, Christian Steidl, MD

Blood (2019) 134 (Supplement_1): 1509.

https://doi.org/10.1182/blood-2019-129730

Published: 2019

Journal Articles

Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 As a Therapeutic Target for Restoring MHC Expression in Diffuse Large B-Cell Lymphoma

Blood (2018) 132 (Supplement 1): 1560.

https://doi.org/10.1182/blood-2018-99-112010

Published: 2018

Journal Articles

The Double-Hit Gene Expression Signature Defines a Clinically and Biologically Distinct Subgroup within GCB-DLBCL

Blood (2018) 132 (Supplement 1): 921.

https://doi.org/10.1182/blood-2018-99-116827

Published: 2018

Journal Articles

Frontline Therapy with Bendamustine and Rituximab (BR) in Follicular Lymphoma: Prognosis Among Patients with Progression of Disease By 24 Months (POD24) Is Poor with Majority Having Transformed Lymphoma

Ciara Louise Freeman, MRCP, MSc, FRCPath, MBBChir, Kerry J Savage, BSc, MD MSc, Diego Villa, MD, David W. Scott, PhDMD, FRACP, FRCPA, Alina S. Gerrie, MD MPH, David J Ferguson, Fergus Cafferty, Graham W Slack, MD, Pedro Farinha, MD PhD, Brian Skinnider, Joseph M. Connors, MD, Laurie H Sehn, MD MPH

Blood (2018) 132 (Supplement 1): 2873.

https://doi.org/10.1182/blood-2018-99-113675

Published: 2018

Journal Articles

Deciphering Discordance between MYC mRNA and MYC IHC in DLBCL: The Role of MYC Exon 2 Mutations and N11S Polymorphism

Blood (2017) 130 (Supplement 1): 3994.

https://doi.org/10.1182/blood.V130.Suppl_1.3994.3994

Published: 2017

Journal Articles

High-Resolution Architecture and Partner Genes of MYC Rearrangements in Lymphoma with DLBCL Morphology

Blood (2017) 130 (Supplement 1): 4007.

https://doi.org/10.1182/blood.V130.Suppl_1.4007.4007

Published: 2017

Journal Articles

Comprehensive MYC and BCL2 Genetic Profiling in De Novo Diffuse Large B-Cell Lymphoma Demonstrates Clinically Relevant Genetic Alterations According to Cell of Origin Subtype

Daisuke Ennishi, MD PhD, Anja Mottok, MD, Kerry J. Savage, MDMSc, Susana Ben-Neriah, Hennady Shulha, Pedro Farinha, MD, Fong Chun Chan, MSc, Barbara Meissner, Merrill Boyle, BSc, Christoffer E Hother, MD PhD, Robert Kridel, MD MPH, Ryan Morin, PhD, Marco A Marra, PhD, Laurie H. Sehn, Christian Steidl, MD, Joseph M. Connors, MD, David W Scott, MBChB, PhD, Randy D. Gascoyne

Blood (2015) 126 (23): 109.

https://doi.org/10.1182/blood.V126.23.109.109

Published: 2015

Journal Articles

Genetic Alterations of Gα13 Signaling Pathway with BCL2 over-Expression Confers Lymphoma Dissemination and Inferior Outcome in Germinal Center B Cell Diffuse Large B Cell Lymphoma

Daisuke Ennishi, MD PhD, Anja Mottok, MD, Hennady Shulha, Pedro Farinha, MD, Fong Chun Chan, MSc, Barbara Meissner, Merrill Boyle, BSc, Susana Ben-Neriah, Christoffer E Hother, MD PhD, Robert Kridel, MD MPH, Ryan Morin, PhD, Marco A Marra, PhD, Kerry J. Savage, MDMSc, Laurie H. Sehn, Joseph M. Connors, MD, Christian Steidl, MD, David W Scott, MBChB, PhD, Randy D. Gascoyne

Blood (2015) 126 (23): 111.

https://doi.org/10.1182/blood.V126.23.111.111

Published: 2015

Journal Articles

The Impact of Concurrent MYC BCL2 Protein Expression on the Risk of Secondary Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma (DLBCL)

Kerry J. Savage, MDMSc, Laurie H. Sehn, MDMPH, Diego Villa, MDMPH, Roopesh R. Kansara, MD, Anja Mottok, MD, Daisuke Ennishi, MDPhD, Susana Ben-Neriah, MSc, Robert Kridel, MDMPH,, Christian Steidl, MD, King L. Tan, MBBS, Nathalie Johnson, MDPhD, Graham W. Slack, MD, Joseph M. Connors, MD, Pedro Farinha, MD, David W. Scott, MBChB, PhD, Randy D. Gascoyne, MD

Blood (2014) 124 (21): 495.

https://doi.org/10.1182/blood.V124.21.495.495

Published: 2014

Journal Articles

Clinical Significance of Genetic Aberrations in Diffuse Large B Cell Lymphoma

Daisuke Ennishi, MD PhD, Christoffer Hoffer, Hennady Shulha, Anja Mottok, MD, Pedro Farinha, MD, Fong Chun Chan, MSc, Barbara Meissner, PhD, Merrill Boyle, B.Sc., Susana Ben-Neriah, MSc, Ryan D Morin, PhD, Marco A. Marra, PhD, Kerry J. Savage, MDMSc, Laurie H. Sehn, MDMPH, Joseph M Connors, MD, Christian Steidl, MD, David W. Scott, MBChB, PhD, Randy D. Gascoyne, MD

Blood (2014) 124 (21): 703.

https://doi.org/10.1182/blood.V124.21.703.703

Published: 2014

Journal Articles

Cell-of-Origin Assignment in Diffuse Large B-Cell Lymphoma Determined By Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Has Prognostic Significance Independent of IPI and MYC/BCL2 Immunohistochemistry

David W. Scott, MBChB, PhD, Anja Mottok, MD, Daisuke Ennishi, MD PhD, George W. Wright, PhD, Pedro Farinha, MD, Susana Ben-Neriah, MSc, Robert Kridel, MD MPH, Garrett S Barry, B.Sc, Christoffer E Hother, MDPhD, Kerry J. Savage, MDMSc, Laurie H. Sehn, MDMPH, Louis M. Staudt, Joseph M. Connors, MD, Lisa M. Rimsza, MD, Randy D. Gascoyne, MD

Blood (2014) 124 (21): 1624.

https://doi.org/10.1182/blood.V124.21.1624.1624

Published: 2014

Journal Articles

A 7-Gene Microrna Signature Characteristic of Mantle Cell Lymphoma Reveals Focal Adhesion and Integrin Signalling, Proteasome-Mediated Degradation, and the PI3K Signalling Cascade As Important to MCL Pathogenesis

Blood (2012) 120 (21): 1586.

https://doi.org/10.1182/blood.V120.21.1586.1586

Published: 2012

Journal Articles

A Gene Expression Signature in Diagnostic Formalin Fixed Paraffin Embedded Tissue Predicts Overall Survival in Locally Advanced and Advanced Stage Classical Hodgkin Lymphoma – a Correlative Study From the E2496 Intergroup Trial

David W Scott, MBChB PhD, Fong Chun Chan, Fangxin Hong, PhD, Sanja Rogic, PhD, King Tan, MBBS, Barbara Meissner, PhD, Pedro Farinha, MD, Sandra J. Horning, MD, Richard I Fisher, MD, Nancy L. Bartlett, MD, Lois E Shepherd, M.D., Joseph M. Connors, MD, Aida B. de Sousa, MD, Brad S. Kahl, MD, Leo I. Gordon, MD, FACP, Christian Steidl, MD, Randy D. Gascoyne, MD

Blood (2011) 118 (21): 430.

https://doi.org/10.1182/blood.V118.21.430.430

Published: 2011

Journal Articles

CSF1R Expression of Hodgkin Reed Sternberg Cells Is Associated with the Number of Macrophages in the Tumor Microenvironment and Is Correlated with Treatment Outcome

Christian Steidl, MD, Arjan Diepstra, MD, PhD, Tang Lee, M.Sc., Pedro Farinha, MD, Adele Telenius, M.Sc., Merrill Boyle, B.Sc., Sohrab P Shah, PhD, Lorena Barclay, Anke Van Den Berg, PhD, Kerry J. Savage, MD MSc, Joseph M. Connors, MD, Randy D. Gascoyne, MD

Blood (2011) 118 (21): 427.

https://doi.org/10.1182/blood.V118.21.427.427

Published: 2011

NARROW

Identification of LAG3+ T Cell Populations in the Tumor Microenvironment of Classical Hodgkin Lymphoma and B-Cell Non-Hodgkin Lymphoma

Rituximab Monotherapy Compared to Observation in Patients with Newly Diagnosed Asymptomatic Advanced Stage Follicular Lymphoma: A Retrospective Population-Based Analysis

Single Cell Profiling Reveals Unique CXCL13 Positive T Cell Subsets in the Tumor Microenvironment of Lymphocyte Rich Classic Hodgkin Lymphoma

Long-Term Follow-up of a PET-Guided Approach to Treatment of Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) in British Columbia (BC)

Single Cell Transcriptome Analysis Reveals Disease-Defining T Cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma

TP53 Expression Correlates with TP53 Mutations and Is an Independent Predictor of Clinical Outcome in Patients with DLBCL Treated with R-CHOP

PRAME Expression Is Correlated with Treatment Outcome and Specific Features of the Tumor Microenvironment in Classical Hodgkin Lymphoma

Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 As a Therapeutic Target for Restoring MHC Expression in Diffuse Large B-Cell Lymphoma

The Double-Hit Gene Expression Signature Defines a Clinically and Biologically Distinct Subgroup within GCB-DLBCL

Frontline Therapy with Bendamustine and Rituximab (BR) in Follicular Lymphoma: Prognosis Among Patients with Progression of Disease By 24 Months (POD24) Is Poor with Majority Having Transformed Lymphoma

Deciphering Discordance between MYC mRNA and MYC IHC in DLBCL: The Role of MYC Exon 2 Mutations and N11S Polymorphism

High-Resolution Architecture and Partner Genes of MYC Rearrangements in Lymphoma with DLBCL Morphology

Comprehensive MYC and BCL2 Genetic Profiling in De Novo Diffuse Large B-Cell Lymphoma Demonstrates Clinically Relevant Genetic Alterations According to Cell of Origin Subtype

Genetic Alterations of Gα13 Signaling Pathway with BCL2 over-Expression Confers Lymphoma Dissemination and Inferior Outcome in Germinal Center B Cell Diffuse Large B Cell Lymphoma

The Impact of Concurrent MYC BCL2 Protein Expression on the Risk of Secondary Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma (DLBCL)

Clinical Significance of Genetic Aberrations in Diffuse Large B Cell Lymphoma

Cell-of-Origin Assignment in Diffuse Large B-Cell Lymphoma Determined By Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Has Prognostic Significance Independent of IPI and MYC/BCL2 Immunohistochemistry

A 7-Gene Microrna Signature Characteristic of Mantle Cell Lymphoma Reveals Focal Adhesion and Integrin Signalling, Proteasome-Mediated Degradation, and the PI3K Signalling Cascade As Important to MCL Pathogenesis

A Gene Expression Signature in Diagnostic Formalin Fixed Paraffin Embedded Tissue Predicts Overall Survival in Locally Advanced and Advanced Stage Classical Hodgkin Lymphoma – a Correlative Study From the E2496 Intergroup Trial

CSF1R Expression of Hodgkin Reed Sternberg Cells Is Associated with the Number of Macrophages in the Tumor Microenvironment and Is Correlated with Treatment Outcome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only